HSPG2 and Alzheimer disease: Previous studies on the brains of patients with AD have reported changes in various types of phospholipids, including PC, PE, and phosphatidylinositol, as well as phospholipid-metabolizing enzymes such as phospholipase C (PLC) and phospholipase D (PLD) (79).